- 22975104OWN - NLMSTAT- MEDLINEDA  - 20120914DCOM- 20130404LR  - 20131121IS  - 1557-3117 (Electronic)IS  - 1053-2498 (Linking)VI  - 31IP  - 10DP  - 2012 OctTI  - Regulation of cyclic adenosine monophosphate release by selective      beta2-adrenergic receptor stimulation in human terminal failing myocardium before      and after ventricular assist device support.PG  - 1127-35LID - 10.1016/j.healun.2012.07.005 [doi]LID - S1053-2498(12)01177-1 [pii]AB  - BACKGROUND: Response to catecholamines is blunted in terminal heart failure due      to beta-receptor downregulation and uncoupling from adenylyl cyclase (AC).      Improved myocardial responsiveness to catecholamines after ventricular assist      device (VAD) support is associated with upregulation of beta1-adrenergic      receptors (beta1-ARs). Little is known about the regulation of AC and beta2-AR      coupling after VAD; moreover beta2-AR stimulation during VAD was claimed to      induce myocardial recovery. METHODS: We analyzed in VAD-supported human      myocardium the regulation of AC activity upon beta1-AR and selective beta2-AR      stimulation in 8 non-failing hearts (NF) and 17 paired samples of VAD patients.      AC messenger RNA was measured by TaqMan. AC was stimulated via beta2-AR using      clenbuterol (beta2-AR agonist) and bisoprolol (beta1-AR blocker). Organ bath      experiments were done with trabeculae from both ventricles. Samples were      stratified according to chronic or acute heart failure history. RESULTS:      Isoprenaline-induced AC activity was downregulated (p < 0.001) pre-VAD and      increased significantly (p < 0.05) after unloading (mean +/- standard deviation      pmole/mg/min) in NF (47.9 +/- 14.9), pre-VAD (24.35 +/- 13.3), and post-VAD      (50.04 +/- 50.25). Forskolin stimulation revealed significant (p < 0.05)      upregulation of AC activity during VAD, especially in acutely failing hearts (NF,      192.1 +/- 68.7; pre-VAD, 191.1 +/- 60.4; post-VAD, 281.5 +/- 133). However,      forskolin stimulation relative to isoprenaline-induced inotropy remained reduced       before and after VAD compared with NF. The selective stimulation of beta2-AR did       not reveal influence of VAD support on beta2-AR-AC coupling. Stimulation of      ventricular trabeculae by > 100 mumole/liter clenbuterol revealed negative      inotropic responses. CONCLUSIONS: VAD does not influence beta2-AR coupling to AC       stimulation. Elevated response to catecholamines after VAD support is influenced       by beta1-AR upregulation and modulation of AC activity. Restoration of      beta-adrenergic responsiveness was restricted to acutely failing hearts.CI  - Copyright (c) 2012 International Society for Heart and Lung Transplantation.      Published by Elsevier Inc. All rights reserved.FAU - Kassner, AstridAU  - Kassner AAD  - Herz- und Diabeteszentrum NRW, Klinik f. Thorax- und Kardiovaskularchirurgie, E.       & H. Klessmann-Institut f. Kardiovaskulare Forschung und Entwicklung, Bad      Oeynhausen, Germany.FAU - Toischer, KarlAU  - Toischer KFAU - Bohms, BirteAU  - Bohms BFAU - Kolkhof, PeterAU  - Kolkhof PFAU - Abraham, GetuAU  - Abraham GFAU - Hasenfubeta, GerdAU  - Hasenfubeta GFAU - Morshuis, MichielAU  - Morshuis MFAU - Schulte Eistrup, SebastianAU  - Schulte Eistrup SFAU - El-Banayosy, AlyAU  - El-Banayosy AFAU - Gummert, JanAU  - Gummert JFAU - Milting, HendrikAU  - Milting HLA  - engPT  - Comparative StudyPT  - Journal ArticlePT  - Research Support, Non-U.S. Gov'tPL  - United StatesTA  - J Heart Lung TransplantJT  - The Journal of heart and lung transplantation : the official publication of the      International Society for Heart TransplantationJID - 9102703RN  - 0 (Adrenergic beta-Agonists)RN  - 0 (Adrenergic beta-Antagonists)RN  - 0 (Catecholamines)RN  - 0 (Receptors, Adrenergic, beta-1)RN  - 0 (Receptors, Adrenergic, beta-2)RN  - 1F7A44V6OU (Colforsin)RN  - E0399OZS9N (Cyclic AMP)RN  - EC 4.6.1.1 (Adenylate Cyclase)RN  - L628TT009W (Isoproterenol)RN  - XTZ6AXU7KN (Clenbuterol)RN  - Y41JS2NL6U (Bisoprolol)SB  - IMMH  - Adenylate Cyclase/metabolismMH  - AdolescentMH  - Adrenergic beta-Agonists/pharmacologyMH  - Adrenergic beta-Antagonists/pharmacologyMH  - AdultMH  - AgedMH  - Bisoprolol/pharmacologyMH  - Catecholamines/pharmacologyMH  - ChildMH  - Clenbuterol/pharmacologyMH  - Colforsin/pharmacologyMH  - Cyclic AMP/*metabolismMH  - FemaleMH  - Heart Failure/*metabolism/*therapyMH  - *Heart-Assist DevicesMH  - HumansMH  - Isoproterenol/pharmacologyMH  - MaleMH  - Middle AgedMH  - Myocardium/*metabolismMH  - Receptors, Adrenergic, beta-1/drug effects/metabolismMH  - Receptors, Adrenergic, beta-2/drug effects/*metabolismMH  - Young AdultEDAT- 2012/09/15 06:00MHDA- 2013/04/05 06:00CRDT- 2012/09/15 06:00PHST- 2011/12/28 [received]PHST- 2012/03/30 [revised]PHST- 2012/07/18 [accepted]AID - S1053-2498(12)01177-1 [pii]AID - 10.1016/j.healun.2012.07.005 [doi]PST - ppublishSO  - J Heart Lung Transplant. 2012 Oct;31(10):1127-35. doi:      10.1016/j.healun.2012.07.005.- 22975104own - nlmstat- medlineda  - 20120914dcom- 20130404lr  - 20131121is  - 1557-3117 (electronic)is  - 1053-2498 (linking)vi  - 31ip  - 10dp  - 2012 octti  - regulation of cyclic adenosine monophosphate release by selective      beta2-adrenergic receptor stimulation in human terminal failing myocardium before      and after ventricular assist device support.pg  - 1127-35lid - 10.1016/j.healun.2012.07.005 [doi]lid - s1053-2498(12)01177-1 [pii]ab  - background: response to catecholamines is blunted in terminal heart failure due      to beta-receptor downregulation and uncoupling from adenylyl cyclase (ac).      improved myocardial responsiveness to catecholamines after ventricular assist      device (vad) support is associated with upregulation of beta1-adrenergic      receptors (beta1-ars). little is known about the regulation of ac and beta2-ar      coupling after vad; moreover beta2-ar stimulation during vad was claimed to      induce myocardial recovery. methods: we analyzed in vad-supported human      myocardium the regulation of ac activity upon beta1-ar and selective beta2-ar      stimulation in 8 non-failing hearts (nf) and 17 paired samples of vad patients.      ac messenger rna was measured by taqman. ac was stimulated via beta2-ar using      clenbuterol (beta2-ar agonist) and bisoprolol (beta1-ar blocker). organ bath      experiments were done with trabeculae from both ventricles. samples were      stratified according to chronic or acute heart failure history. results:      isoprenaline-induced ac activity was downregulated (p < 0.001) pre-vad and      increased significantly (p < 0.05) after unloading (mean +/- standard deviation      pmole/mg/min) in nf (47.9 +/- 14.9), pre-vad (24.35 +/- 13.3), and post-vad      (50.04 +/- 50.25). forskolin stimulation revealed significant (p < 0.05)      upregulation of ac activity during vad, especially in acutely failing hearts (nf,      192.1 +/- 68.7; pre-vad, 191.1 +/- 60.4; post-vad, 281.5 +/- 133). however,      forskolin stimulation relative to isoprenaline-induced inotropy remained reduced       before and after vad compared with nf. the selective stimulation of beta2-ar did       not reveal influence of vad support on beta2-ar-ac coupling. stimulation of      ventricular trabeculae by > 100 mumole/liter clenbuterol revealed negative      inotropic responses. conclusions: vad does not influence beta2-ar coupling to ac       stimulation. elevated response to catecholamines after vad support is influenced       by beta1-ar upregulation and modulation of ac activity. restoration of      beta-adrenergic responsiveness was restricted to acutely failing hearts.ci  - copyright (c) 2012 international society for heart and lung transplantation.      published by elsevier inc. all rights reserved.fau - kassner, astridau  - kassner aad  - herz- und diabeteszentrum nrw, klinik f. thorax- und kardiovaskularchirurgie, e.       & h. klessmann-institut f. kardiovaskulare forschung und entwicklung, bad      oeynhausen, germany.fau - toischer, karlau  - toischer kfau - bohms, birteau  - bohms bfau - kolkhof, peterau  - kolkhof pfau - abraham, getuau  - abraham gfau - hasenfubeta, gerdau  - hasenfubeta gfau - morshuis, michielau  - morshuis mfau - schulte eistrup, sebastianau  - schulte eistrup sfau - el-banayosy, alyau  - el-banayosy afau - gummert, janau  - gummert jfau - milting, hendrikau  - milting hla  - engpt  - comparative studypt  - journal articlept  - research support, non-u.s. gov'tpl  - united statesta  - j heart lung transplantjt  - the journal of heart and lung transplantation : the official publication of the      international society for heart transplantationjid - 9102703rn  - 0 (adrenergic beta-agonists)rn  - 0 (adrenergic beta-antagonists)rn  - 0 (catecholamines)rn  - 0 (receptors, adrenergic, beta-1)rn  - 0 (receptors, adrenergic, beta-2)rn  - 1f7a44v6ou (colforsin)rn  - e0399ozs9n (cyclic amp)rn  - ec 4.6.1.1 (adenylate cyclase)rn  - l628tt009w (isoproterenol)rn  - xtz6axu7kn (clenbuterol)rn  - y41js2nl6u (bisoprolol)sb  - immh  - adenylate cyclase/metabolismmh  - adolescentmh  - adrenergic beta-agonists/pharmacologymh  - adrenergic beta-antagonists/pharmacologymh  - adultmh  - agedmh  - bisoprolol/pharmacologymh  - catecholamines/pharmacologymh  - childmh  - clenbuterol/pharmacologymh  - colforsin/pharmacologymh  - cyclic amp/*metabolismmh  - femalemh  - heart failure/*metabolism/*therapymh  - *heart-assist devicesmh  - humansmh  - isoproterenol/pharmacologymh  - malemh  - middle agedmh  - myocardium/*metabolismmh  - receptors, adrenergic, beta-1/drug effects/metabolismmh  - receptors, adrenergic, beta-2/drug effects/*metabolismmh  - young adultedat- 2012/09/15 06:00mhda- 2013/04/05 06:00crdt- 2012/09/15 06:00phst- 2011/12/28 [received]phst- 2012/03/30 [revised]phst- 2012/07/18 [accepted]aid - s1053-2498(12)01177-1 [pii]aid - 10.1016/j.healun.2012.07.005 [doi]pst - ppublishso  - j heart lung transplant. 2012 oct;31(10):1127-35. doi:      10.1016/j.healun.2012.07.005.